Literature DB >> 20962786

Does immunosuppressant medication lower blood pressure and arterial stiffness in patients with chronic kidney disease? An observational study.

Charles J Ferro1, Nicola C Edwards, Colin Hutchison, Paul Cockwell, Rick P Steeds, Caroline O Savage, Jonathan N Townend, Lorraine Harper.   

Abstract

Chronic kidney disease is a proinflammatory state associated with increased arterial stiffness. We hypothesized that chronic kidney disease patients on long-term immunosuppression would have lower arterial stiffness and require treatment with less antihypertensive medication compared with non-immunosuppressed patients. A total of 254 patients (97 on immunosuppression) with chronic kidney disease were recruited from specialist renal clinics. Brachial blood pressure, central aortic pressure and waveform and pulse wave velocity were measured. Age, peripheral blood pressure and pulse wave velocity increased with worsening renal function but were not different between immunosuppressed and non-immunosuppressed patients. Central systolic (P < 0.001) and pulse pressure (P = 0.003) and the number of antihypertensive medications (P < 0.001) increased with worsening renal function and were higher in non-immunosuppressed patients (P = 0.02, P = 0.004 and P < 0.001, respectively). Age, mean arterial pressure, number of antihypertensive medications and a diagnosis of diabetes were found to be independent predictors of pulse wave velocity (R(2) = 0.375; P < 0.001). In a subgroup of 30 patient pairs without diabetes mellitus and cardiovascular disease and with a proven renal diagnosis, carefully matched for age, gender, renal function and systolic pressure, the prescribed antihypertensive medication remained lower in the immunosuppressed patients compared with non-immunosuppressed patients (P = 0.04). Pulse wave velocity was lower in the immunosuppressed group (7.5 ± 1.8 vs. 8.8 ± 1.9 m s(-1); P = 0.02). This study suggests that immunosuppression might be a method of reducing blood pressure and arterial stiffness in patients with chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962786     DOI: 10.1038/hr.2010.193

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  10 in total

Review 1.  National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness: Building on the Current Scientific Evidence.

Authors:  Young S Oh; Lawrence J Appel; Zorina S Galis; David A Hafler; Jiang He; Amanda L Hernandez; Bina Joe; S Ananth Karumanchi; Christine Maric-Bilkan; David Mattson; Nehal N Mehta; Gwendolyn Randolph; Michael Ryan; Kathryn Sandberg; Jens Titze; Eser Tolunay; Glenn M Toney; David G Harrison
Journal:  Hypertension       Date:  2016-06-20       Impact factor: 10.190

Review 2.  Inflammation, Immunity, and Oxidative Stress in Hypertension-Partners in Crime?

Authors:  Ian R Barrows; Ali Ramezani; Dominic S Raj
Journal:  Adv Chronic Kidney Dis       Date:  2019-03       Impact factor: 3.620

Review 3.  ORAI channels in cellular remodeling of cardiorespiratory disease.

Authors:  Martin Johnson; Mohamed Trebak
Journal:  Cell Calcium       Date:  2019-02-08       Impact factor: 6.817

Review 4.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

5.  Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.

Authors:  Keisa W Mathis; Marcia Venegas-Pont; C Warren Masterson; Nicholas J Stewart; Katie L Wasson; Michael J Ryan
Journal:  Hypertension       Date:  2012-01-30       Impact factor: 10.190

Review 6.  Autoimmunity: an underlying factor in the pathogenesis of hypertension.

Authors:  Keisa W Mathis; Hanna J Broome; Michael J Ryan
Journal:  Curr Hypertens Rep       Date:  2014-04       Impact factor: 5.369

Review 7.  Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension.

Authors:  Quynh N Dinh; Grant R Drummond; Christopher G Sobey; Sophocles Chrissobolis
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

8.  CD4+CD28null T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis.

Authors:  Marjan C Slot; Abraham A Kroon; Jan G M C Damoiseaux; Ruud Theunissen; Alfons J H M Houben; Peter W de Leeuw; Jan Willem Cohen Tervaert
Journal:  Rheumatol Int       Date:  2017-01-13       Impact factor: 2.631

9.  Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same?

Authors:  Edoardo Melilli; Anna Manonelles; Nuria Montero; Josep Grinyo; Alberto Martinez-Castelao; Oriol Bestard; Josep Cruzado
Journal:  Clin Kidney J       Date:  2017-11-23

10.  Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus.

Authors:  Victoria L Wolf; Erin B Taylor; Michael J Ryan
Journal:  Physiol Rep       Date:  2019-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.